STAT+: Can a top Republican from a bygone political era fix pharma’s woes in Washington? — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Eric Cantor served as House majority leader in 2013 and was described as the party's 'de facto chief political strategist' while at a Virginia resort with Republican colleagues, per the article.
- The GOP was working to shift away from its stereotype as a party focused on 'the rich and their corporate interests,' framed against 'growing populist currents' in the country.
- Cantor was seen by contemporaries as the strategist best positioned to help Republicans 'improve the lives of everyday people,' according to a New Yorker profile cited in the STAT+ piece.
- The full article is locked behind the STAT+ paywall — the headline frames Cantor's return as relevant to pharmaceutical industry challenges in Washington, but the visible excerpt contains no details on his current role or pharma connections.
Why it matters: STAT+, a health-and-pharma-focused outlet, is using Cantor's 2013 credentials as the GOP's 'de facto chief political strategist' as the framing device for profiling his current Washington role. The visible excerpt offers only historical setup; the substance about his present-day position and any pharma ties is gated behind a subscription wall.
Ask SkimNews
